Other

Actavis to spend $66 billion on Allergan

Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.

Neuroscience

When brain says buy, you may not know why

Billions of neurons fire in the brains of stock market traders as they decide whether to buy or sell shares in a matter of seconds. Some of these brain waves produce rational calculations about how best to make a profit, ...

Other

AmSurg to buy Sheridan Healthcare for about $2.35B

AmSurg says it will spend about $2.35 billion to buy Sheridan Healthcare in a cash and stock deal that adds physician outsourcing services to the ambulatory surgery center operator's portfolio.

page 11 from 14